About BIONET THERAPEUTICS CORP
Sector
CEO
Cheng Hsien Tsai
Website
Headquarters
Taipei
Founded
2022
ISIN
TW0007808008
FIGI
BBG01R41SKG0
BIONET Therapeutics Corp. engages in the development of cell therapy products. Its products include cell therapy and CRDMO services. The firm focuses on regenerative medicinal products, tech-enabled research and development, exosomes and cell therapy. The company was founded on June 15, 2022 and is headquartered in Taipei, Taiwan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 7808 is 47.00 TWD — it has decreased by −0.62% in the past 24 hours. Watch BIONET THERAPEUTICS CORP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange BIONET THERAPEUTICS CORP stocks are traded under the ticker 7808.
7808 stock has risen by 6.71% compared to the previous week, the month change is a −23.06% fall, over the last year BIONET THERAPEUTICS CORP has showed a −24.19% decrease.
7808 reached its all-time high on Dec 12, 2024 with the price of 72.60 TWD, and its all-time low was 42.40 TWD and was reached on Dec 20, 2024. View more price dynamics on 7808 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
No, 7808 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 7808 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIONET THERAPEUTICS CORP stock right from TradingView charts — choose your broker and connect to your account.